English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| May 7, 2023
Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance
Patient Daily
| May 7, 2023
Horizon Therapeutics plc Reports First-Quarter 2023 Financial Results
Patient Daily
| May 7, 2023
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
Patient Daily
| May 7, 2023
Integra LifeSciences Reports First Quarter 2023 Financial Results
Patient Daily
| May 7, 2023
EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS
Patient Daily
| May 7, 2023
Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
Patient Daily
| May 7, 2023
Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance
Patient Daily
| May 4, 2023
Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results
Trending
+
Pharmaceuticals
Patient Daily
| Oct 23, 2025
Empower seeks dismissal of Eli Lilly suit in Texas federal court
Patient Daily
| Oct 23, 2025
Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
Patient Daily
| Oct 23, 2025
Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
+
Pharmaceuticals
Patient Daily
| Oct 29, 2025
Paragon Health Institute senior fellow: 340B program 'needs real reform'
« First
«
1
2
3
4
5
6
…
»
Last »